TABLE 1.
Characteristic | Value |
---|---|
Age, years | 57.7 (50.8-63.8) |
Female sex | 211 (37) |
Race | |
Caucasian | 477 (83) |
African American | 73 (13) |
Other | 22 (4) |
BMI, kg/m2 | 27.2 (23.5-32.2) |
Year of transplantation | |
2002-2006 | 164 (29) |
2007-2010 | 130 (23) |
2011-2014 | 178 (31) |
2015-2017 | 100 (17) |
Indication for SLKT | |
AKD | 237 (41) |
CKD | 303 (53) |
Indeterminate | 32 (6) |
Days with eGFR <60 mL/minute/1.73 m2 | 204 (60-672) |
Days with eGFR <25 mL/minute/1.73 m2 | 67 (22-259) |
Hemodialysis at listing | 224 (39) |
Days on hemodialysis before SLKT | 13 (0-94) |
Hepatitis C | 188 (33) |
EtOH related | 132 (23) |
NASH | 110 (19) |
Diabetes mellitus | 239 (42) |
Hypertension | 303 (53) |
Coronary artery disease | 116 (20) |
MELD at SLKT | 30 (25-36) |
Serum creatinine at SLKT (mg/dL) | 3.0 (2.1-4.6) |
Ascites | |
None | 138 (24) |
Mild | 74 (13) |
Moderate | 180 (31) |
Refractory | 180 (31) |
Hepatic encephalopathy | 363 (63) |
Hospitalization status | |
Home | 171 (30) |
Medical ward | 76 (13) |
Intensive care unit | 325 (57) |
Mechanical ventilation | 119 (21) |
Hemodialysis at SLKT | 212 (37) |
Cold ischemia time (min) | 360 (300-477) |
Warm ischemia time (min) | 38 (23-60) |
Donor distance | |
Local | 522 (91) |
Regional | 36 (6) |
National | 14 (2) |
Delayed graft function | 131 (23) |
NOTE: The data are expressed as median (IQR) or n (%).